3rd Annual Artificial Intelligence in Drug Development Congress

Memo

We will welcome over 450 artificial intelligence and pharmaceutical IT attendees representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions Over 30 presentations, case studies and panel discussions focussed on the innovative application of artificial intelligence in drug discovery and cheminformatics, alongside machine learning in clinical trials and big data. Including 3 Interactive Streams: - AI in Drug Discovery and Discovery Chemistry- Machine Learning and Personalising Patient Treatments- AI in Big Data and Clinical Research Development Co-located with our 17th Pharmaceutical IT Congress, SmartLabs and Laboratory Informatics Congress and Cyber Security and Data Protection in Pharma and Healthcare Congress. 14 pre-scheduled one to one meetings, exhibition spaces and informal networking opportunities URLs: Brochure: https://go.evvnt.com/407026-0?pid=5569,Tickets: https://go.evvnt.com/407026-1?pid=5569 Price:Tickets available from: GBP 299.0. Speakers: James Weatherall, Executive Director and Head of Advanced Analytics, AstraZeneca , Claus Bendtsen, Executive Director, AstraZeneca , Ray Liu, Senior Director and Head, Advanced Analytics and Statistical Consultation, Takeda, George Okafo, Senior Director, Insilico Drug Discovery Unit, GlaxoSmithKline, Hugo Ceulemans, Scientific Director Discovery Data Sciences, Janssen. Time: 7:30 am to 7:00 pm. Venue details: ILEC Conference Centre, 47 Lillie Road, London, SW6 1UD, United Kingdom.